
Survodutide
CAS: 2805997-46-8
Survodutide is a research peptide in the glp-1 / weight management category. Survodutide is a dual glucagon/GLP-1 receptor agonist that combines GLP-1-mediated appetite suppression and insulin secretion with glucagon receptor-mediated increases in energy expenditure and hepatic fat oxidation. MiPeptidos offers Survodutide in 1 sizes with 99.1% verified purity and full analytical documentation.
How Survodutide Works
Survodutide is a dual glucagon/GLP-1 receptor agonist that combines GLP-1-mediated appetite suppression and insulin secretion with glucagon receptor-mediated increases in energy expenditure and hepatic fat oxidation. The glucagon component drives thermogenesis and lipolysis while the GLP-1 activity counterbalances any hyperglycemic effects of glucagon activation. This dual mechanism provides both weight loss and liver fat reduction.
Research Applications
Pricing
| Size | Per Vial | 10-Pack |
|---|---|---|
10mg | $103.95 | $758.95 |
Prices shown per vial from 10-pack. Volume discounts available for 50+ vials — contact us.
HPLC Purity Analysis
Certificate of Analysis
This COA is a representative sample. A batch-specific Certificate of Analysis with full HPLC chromatograms and mass spectrometry data is included with every MiPeptidos order.
Reconstitution Calculator
Inject bacteriostatic water slowly along the vial wall. Gently swirl until dissolved — never shake. Store reconstituted solution at 2-8°C and use within 30 days.
Download Product Brochure
Get our detailed Survodutide product brochure with specifications, research applications, HPLC analysis data, and reconstitution guide. Available in English and Spanish.
Customer Reviews
Frequently Asked Questions
Specifications
Sequence
29-amino acid acylated peptide with 1-aminocyclobutane-1-carboxylic acid (Ac4c) at position 2, C18 fatty diacid conjugation, and C-terminal amidation
Research Use Only. This product is intended for laboratory research purposes only. Not for human consumption. Handle with appropriate safety precautions.
Related Peptides

Semaglutide
A glucagon-like peptide-1 (GLP-1) receptor agonist originally developed for glycemic control. Widely studied for its role in appetite regulation and metabolic research.

Tirzepatide
A dual GIP/GLP-1 receptor agonist studied for its effects on glucose metabolism and body weight regulation. One of the most researched peptides in the incretin class.

Retatrutide
A triple agonist targeting GIP, GLP-1, and glucagon receptors. Investigated in preclinical and clinical research for its multi-pathway approach to metabolic regulation.

Liraglutide
A GLP-1 receptor agonist with an extended half-life due to fatty acid acylation. Extensively studied for glucose homeostasis and appetite signaling research.